Centene Corp vs iShares Core S&P 500 ETF — how do they compare? Centene Corp trades at $65.13 (market cap $32.89B), while iShares Core S&P 500 ETF trades at $775.82. Which is the better fit depends on your goals.
| CNC | IVV | |
|---|---|---|
Market Cap | $32.89B | — |
Sector | Health | Broad Market / Factor |
52-Week High | $68.72 | $776.81 |
52-Week Low | $26.17 | $634.93 |
Enterprise Value | $21.93B | — |
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
IVV, tracking the S&P 500, trades at $776.81, up 0.6% with a bullish technical signal from moving averages. The ETF approaches resistance near $779-$784 amid strong institutional interest, including a 24.8% position increase by First Bank & Trust. Recent news highlights record highs and JPMorgan's raised 2026 target to 8,000, driven by AI-fueled earnings growth.
Outlook remains positive with S&P 500 earnings growth up 51.1% year-over-year, but risks include overbought conditions (RSI_6 at 94.32) and potential consolidation. Investor sentiment is greedy, yet weak market breadth and high valuations warrant caution for near-term volatility.
Trailing returns across standard periods
Latest headlines on both assets
Centene is a managed-care organization focused on government-sponsored healthcare plans, including Medicaid, Medicare, and the individual exchanges. Centene served 22 million medical members as of September 2021, mostly in Medicaid (68% of membership), the individual exchanges (10%), Medicare Advantage (6%), and the balance in Tricare (West region), correctional facility, and international plans. The company also serves 4 million users through the Medicare Part D pharmaceutical program.
Read more on CNC →IVV tracks the performance of the S&P 500 Index, offering low-cost exposure to 500 of the largest US companies. It is a cornerstone for long-term investors seeking broad growth in the US stock market.
Read more on IVV →